Tredje AP fonden Sells 3,000 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Tredje AP fonden reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 9.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 28,536 shares of the medical equipment provider’s stock after selling 3,000 shares during the period. Tredje AP fonden’s holdings in Intuitive Surgical were worth $14,895,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Berbice Capital Management LLC acquired a new position in Intuitive Surgical in the fourth quarter valued at approximately $26,000. BankPlus Trust Department bought a new stake in Intuitive Surgical during the fourth quarter worth $28,000. Kohmann Bosshard Financial Services LLC bought a new position in Intuitive Surgical in the 4th quarter valued at $31,000. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical in the 3rd quarter valued at $33,000. Finally, Decker Retirement Planning Inc. bought a new position in Intuitive Surgical in the 4th quarter valued at $36,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts recently issued reports on ISRG shares. Piper Sandler reissued an “overweight” rating and set a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Leerink Partners increased their price objective on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Citigroup increased their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Raymond James raised their price target on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Finally, JPMorgan Chase & Co. lifted their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $613.10.

View Our Latest Research Report on Intuitive Surgical

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Brian Edward Miller sold 8,900 shares of Intuitive Surgical stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the sale, the executive vice president now directly owns 5,758 shares in the company, valued at approximately $2,793,033.06. The trade was a 60.72 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Mark Brosius sold 489 shares of the company’s stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $533.18, for a total transaction of $260,725.02. Following the completion of the transaction, the senior vice president now owns 2,091 shares of the company’s stock, valued at approximately $1,114,879.38. This trade represents a 18.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 22,209 shares of company stock valued at $11,928,127. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $497.30 on Thursday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The stock has a market cap of $177.13 billion, a price-to-earnings ratio of 77.58, a PEG ratio of 5.85 and a beta of 1.43. The stock’s 50 day moving average price is $569.42 and its 200 day moving average price is $531.60.

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

See Also

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.